Kamil S. Salikhov
Kamil S. Salikhov has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- S. B. Butsan
Central Research Institute of Dentistry and Maxillofacial Surgery
4 shared publications - A. A. Gaybadulina
Central Research Institute of Dentistry and Maxillofacial Surgery
2 shared publications - Lesya B. Zavaliy
Sklifosovsky Research Institute of Emergency Care
2 shared publications - M. N. Bolshakov
Central Research Institute of Dentistry and Maxillofacial Surgery
2 shared publications - Marina B. Gushchina
Central Research Institute of Dental and Maxillofacial Surgery, Moscow, Russia
2 shared publications - Mikhail Vladimirovich Sinkin
N.I. Pirogov Russian National Research Medical University; N.V. Sklifosovsky Scientific Research Institute of Emergency Medicine of the Moscow City Health Department
2 shared publications
Latest Publications
- 23 October 2026
- Published by Science and Innovation Center
Facial nerve neuropathy following neurosurgical treatment of space-occupying lesions in the cerebellopontine angle
В учебно-методическом пособии представлены базовые принципы клинико-инструментальной диагностики поражения лицевого нерва после удаления опухоли мостомозжечкового угла, а также основные подходы к консервативному и хирургическому лечению. Пособие базируется на клинических рекомендациях, справочной литературе. Для нейрохирургов, неврологов, реабилитологов, врачей функциональной диагностики (нейрофизиологов).
- 23 October 2026
- Published by Science and Innovation Center
Facial nerve neuropathy following neurosurgical treatment of space-occupying lesions in the cerebellopontine angle
В учебно-методическом пособии представлены базовые принципы клинико-инструментальной диагностики поражения лицевого нерва после удаления опухоли мостомозжечкового угла, а также основные подходы к консервативному и хирургическому лечению. Пособие базируется на клинических рекомендациях, справочной литературе. Для нейрохирургов, неврологов, реабилитологов, врачей функциональной диагностики (нейрофизиологов).
- Open Access
- 15 April 2025
- Published by Periodontal Association - RPA in Parodontologiya
Simultaneous dental implant placement in extensive jaw defects: a series of clinical cases
Relevance. Despite advances in the reconstruction of extensive jaw defects using vascularized autografts, the issue of multi-stage treatment for such patients remains clinically significant.Objective. To enhance treatment outcomes in patients with extensive jaw defects and deformities by performing simultaneous dental implant placement during reconstruction with vascularized autografts, thereby shortening the overall treatment and rehabilitation period.Clinical case description. Using the proposed approach, five patients aged 19 to 44 years were treated for extensive jaw defects – one affecting the maxilla and four involving the mandible. All patients underwent multislice computed tomography (MSCT) of the skull before and after surgery to assess treatment outcomes. During the preoperative planning stage, virtual surgical simulation was performed, and patient-specific cutting guides were fabricated for jaw resection, osteotomy of the vascularized fibular autograft, and dental implant placement. Postoperative assessments, conducted in accordance with the research protocol, confirmed the effectiveness of simultaneous dental implant placement during jaw reconstruction with vascularized autografts. Current data indicate that this method improves treatment efficiency and significantly reduces the rehabilitation period in patients with extensive jaw defects.Conclusion. The proposed approach – jaw reconstruction using vascularized autografts in combination with simultaneous dental implant placement – proves to be effective. It supports both functional and aesthetic rehabilitation while considerably shortening the recovery period for patients with extensive jaw defects.
- 15 April 2025
- Published by Periodontal Association - RPA in Parodontologiya
Open AccessSimultaneous dental implant placement in extensive jaw defects: a series of clinical cases
Relevance. Despite advances in the reconstruction of extensive jaw defects using vascularized autografts, the issue of multi-stage treatment for such patients remains clinically significant.Objective. To enhance treatment outcomes in patients with extensive jaw defects and deformities by performing simultaneous dental implant placement during reconstruction with vascularized autografts, thereby shortening the overall treatment and rehabilitation period.Clinical case description. Using the proposed approach, five patients aged 19 to 44 years were treated for extensive jaw defects – one affecting the maxilla and four involving the mandible. All patients underwent multislice computed tomography (MSCT) of the skull before and after surgery to assess treatment outcomes. During the preoperative planning stage, virtual surgical simulation was performed, and patient-specific cutting guides were fabricated for jaw resection, osteotomy of the vascularized fibular autograft, and dental implant placement. Postoperative assessments, conducted in accordance with the research protocol, confirmed the effectiveness of simultaneous dental implant placement during jaw reconstruction with vascularized autografts. Current data indicate that this method improves treatment efficiency and significantly reduces the rehabilitation period in patients with extensive jaw defects.Conclusion. The proposed approach – jaw reconstruction using vascularized autografts in combination with simultaneous dental implant placement – proves to be effective. It supports both functional and aesthetic rehabilitation while considerably shortening the recovery period for patients with extensive jaw defects.
- 23 November 2022
- Published by Medical Informational Agency Publishers in Russian neurological Journal
- Vol. 27 (5) , 14-22
Synkinesis in patients with neuropathy of the facial nerve
Facial synkinesis is involuntary contractions of unrelated groups of facial muscles that occur during voluntary movement. The article presents a review of scientific literature of the problem pathological synkinesis as a complication of facial neuropathy. The mechanism of their development and the main theories of occurrence are described. We describе the types (patterns) of synkinesis, methods for theirs detecting, description of clinical manifestations, methods of instrumental diagnostics. We reviewed approaches to treatment and rehabilitation, the main types of conservative and surgical treatment.
- 23 November 2022
- Published by Medical Informational Agency Publishers in Russian neurological Journal
- Vol. 27 (5) , 14-22
Synkinesis in patients with neuropathy of the facial nerve
Facial synkinesis is involuntary contractions of unrelated groups of facial muscles that occur during voluntary movement. The article presents a review of scientific literature of the problem pathological synkinesis as a complication of facial neuropathy. The mechanism of their development and the main theories of occurrence are described. We describе the types (patterns) of synkinesis, methods for theirs detecting, description of clinical manifestations, methods of instrumental diagnostics. We reviewed approaches to treatment and rehabilitation, the main types of conservative and surgical treatment.
- 1 January 2022
- Published by Media Sphere Publishing Group in Plastic Surgery and Aesthetic Medicine
- No. 3
Midface soft tissue defect closure with medial sural artery perforator flap
ЦЕЛЬ ИССЛЕДОВАНИЯ Повышение эффективности хирургического лечения и реабилитации больных с мягкотканными дефектами средней зоны лица. МАТЕРИАЛ И МЕТОДЫ В клиническом исследовании приняли участие 11 пациентов с мягкотканными дефектами и деформациями средней зоны лица; 10 пациентам дефекты устранили с использованием свободного лоскута на перфоранте медиальной икроножной артерии (ПЛМИА — перфорантный лоскут медиальной икроножной артерии). Выяснили этиологию возникновения дефектов, в последующем они были разделены согласно классификации J.S. Brown и R.J. Shaw (2010). Степень хирургического и анестезиологического рисков была оценена согласно шкале ACS NSQIP. Определили основные клинические характеристики лоскута и возможности его применения: размеры и толщину лоскута, количество перфорантных сосудов, участвующих в его кровоснабжении, длину сосудистой ножки. Динамическое наблюдение за пациентами позволило определить донорский ущерб. РЕЗУЛЬТАТЫ В 10 из 11 случаев нами был использован ПЛМИА для устранения дефектов средней зоны лица. В одном случае интраоперационно было принято решение отказаться от использования ПЛМИА. Площадь дефекта в среднем составляла 22,9 см2. Размеры выделенных лоскутов варьировали от 3×4 см до 9×8 см, длина сосудистой ножки составляла от 11 до 16 см, толщина — от 0,4 до 0,9 см. В 3 случаях были сохранены по 2 перфоранта на лоскуте. Реципиентными сосудами выступали: верхнещитовидная, лицевая, подподбородочная, поверхностная височная артерии и вены и язычная вена. Средний показатель хирургического риска развития «серьезного осложнения» составил 25,16%, «любого другого осложнения» — 30,53% согласно результатам проведенного анализа по ACS NSQIP. ЗАКЛЮЧЕНИЕ Благодаря постоянству анатомии заднемедиальной поверхности голени, небольшой толщине подкожно-жировой клетчатки, возможности выделения различных размеров лоскута, длине сосудистой ножки, минимальному донорскому ущербу ПЛМИА является хорошим пластическим материалом для устранения дефектов мягких тканей средней зоны лица.
- 1 January 2022
- Published by Media Sphere Publishing Group in Plastic Surgery and Aesthetic Medicine
- No. 3
Midface soft tissue defect closure with medial sural artery perforator flap
ЦЕЛЬ ИССЛЕДОВАНИЯ Повышение эффективности хирургического лечения и реабилитации больных с мягкотканными дефектами средней зоны лица. МАТЕРИАЛ И МЕТОДЫ В клиническом исследовании приняли участие 11 пациентов с мягкотканными дефектами и деформациями средней зоны лица; 10 пациентам дефекты устранили с использованием свободного лоскута на перфоранте медиальной икроножной артерии (ПЛМИА — перфорантный лоскут медиальной икроножной артерии). Выяснили этиологию возникновения дефектов, в последующем они были разделены согласно классификации J.S. Brown и R.J. Shaw (2010). Степень хирургического и анестезиологического рисков была оценена согласно шкале ACS NSQIP. Определили основные клинические характеристики лоскута и возможности его применения: размеры и толщину лоскута, количество перфорантных сосудов, участвующих в его кровоснабжении, длину сосудистой ножки. Динамическое наблюдение за пациентами позволило определить донорский ущерб. РЕЗУЛЬТАТЫ В 10 из 11 случаев нами был использован ПЛМИА для устранения дефектов средней зоны лица. В одном случае интраоперационно было принято решение отказаться от использования ПЛМИА. Площадь дефекта в среднем составляла 22,9 см2. Размеры выделенных лоскутов варьировали от 3×4 см до 9×8 см, длина сосудистой ножки составляла от 11 до 16 см, толщина — от 0,4 до 0,9 см. В 3 случаях были сохранены по 2 перфоранта на лоскуте. Реципиентными сосудами выступали: верхнещитовидная, лицевая, подподбородочная, поверхностная височная артерии и вены и язычная вена. Средний показатель хирургического риска развития «серьезного осложнения» составил 25,16%, «любого другого осложнения» — 30,53% согласно результатам проведенного анализа по ACS NSQIP. ЗАКЛЮЧЕНИЕ Благодаря постоянству анатомии заднемедиальной поверхности голени, небольшой толщине подкожно-жировой клетчатки, возможности выделения различных размеров лоскута, длине сосудистой ножки, минимальному донорскому ущербу ПЛМИА является хорошим пластическим материалом для устранения дефектов мягких тканей средней зоны лица.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 138 (3) , 102-109
Treatment of neurotrophic keratopathy in combined lesions of the trigeminal and facial nerves
Ocular symptomatology in lesions of the facial nerve is associated with disturbed innervation of the circular muscle of the eye that leads to disruption of the protective function of the eyelids and the development of exposure symptoms, and is accompanied by a breach in corneal tear film integrity. The main clinical manifestation of the trigeminal nerve damage is the loss of sensory innervation of the cornea and disruption of the supply of neurotransmitters to its cells, manifesting as corneal hypo- or anesthesia. This triggers a cascade of pathological processes that lead to the development of neurotrophic keratopathy. In combined pathology of the facial and trigeminal nerves, a number of interrelated and mutually aggravating problems arise that require correction of lagophthalmos and functional restoration of the trigeminal nerve, since there is an interaction between the corneal epithelium and trigeminal neurons through trophic neuromodulators, which normally contribute to the proliferation of epithelial cells, their differentiation, migration and adhesion, and are essential for vital functions, metabolism and healing of surface lesions of the eye. Classical methods of treating neurotrophic keratopathy aim to protect the ocular surface, and are palliative or auxiliary, do not provide radical relief of the symptoms of neurotrophic keratopathy. Modern surgical technique of neurotization of the cornea allows restoring the structural growth of the nerve, which provides nerve trophism and corneal sensitivity, and is the only pathogenetically substantiated method of effective treatment of neurotrophic keratopathy. At the same time, direct neurotization has undeniable advantages over methods involving intercalary donor nerves, since neuropeptides from nerve fibers are immediately released into the recipient tissue and start reparative processes. Taking into account the accumulated positive experience of neurotization surgeries, scientific and clinical research should be continued in order to improve the most effective methods of corneal neurotization and promote their wider implementation into clinical practice.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 138 (3) , 102-109
Treatment of neurotrophic keratopathy in combined lesions of the trigeminal and facial nerves
Ocular symptomatology in lesions of the facial nerve is associated with disturbed innervation of the circular muscle of the eye that leads to disruption of the protective function of the eyelids and the development of exposure symptoms, and is accompanied by a breach in corneal tear film integrity. The main clinical manifestation of the trigeminal nerve damage is the loss of sensory innervation of the cornea and disruption of the supply of neurotransmitters to its cells, manifesting as corneal hypo- or anesthesia. This triggers a cascade of pathological processes that lead to the development of neurotrophic keratopathy. In combined pathology of the facial and trigeminal nerves, a number of interrelated and mutually aggravating problems arise that require correction of lagophthalmos and functional restoration of the trigeminal nerve, since there is an interaction between the corneal epithelium and trigeminal neurons through trophic neuromodulators, which normally contribute to the proliferation of epithelial cells, their differentiation, migration and adhesion, and are essential for vital functions, metabolism and healing of surface lesions of the eye. Classical methods of treating neurotrophic keratopathy aim to protect the ocular surface, and are palliative or auxiliary, do not provide radical relief of the symptoms of neurotrophic keratopathy. Modern surgical technique of neurotization of the cornea allows restoring the structural growth of the nerve, which provides nerve trophism and corneal sensitivity, and is the only pathogenetically substantiated method of effective treatment of neurotrophic keratopathy. At the same time, direct neurotization has undeniable advantages over methods involving intercalary donor nerves, since neuropeptides from nerve fibers are immediately released into the recipient tissue and start reparative processes. Taking into account the accumulated positive experience of neurotization surgeries, scientific and clinical research should be continued in order to improve the most effective methods of corneal neurotization and promote their wider implementation into clinical practice.
- 1 January 2022
- Published by Media Sphere Publishing Group in Plastic Surgery and Aesthetic Medicine
- No. 1
Anatomical and functional justification of the use of supraorbital and supratrochlear nerves for direct corneal neurotization in patients with combined pathology of the trigeminal and other cranial nerves
- 1 January 2022
- Published by Media Sphere Publishing Group in Plastic Surgery and Aesthetic Medicine
- No. 1
Anatomical and functional justification of the use of supraorbital and supratrochlear nerves for direct corneal neurotization in patients with combined pathology of the trigeminal and other cranial nerves